Innovative Therapeutics Adoption AppliedVR’s FDA-authorized VR-based medical device, RelieVRx, demonstrates the company’s pioneering role in immersive therapeutics, creating opportunities to expand into healthcare providers seeking cutting-edge non-pharmacological pain management solutions.

Expanding Market Reach Recent launches of RelieVRx for workers' compensation patients indicate a strategic focus on integrating immersive pain management into occupational health and insurance sectors, opening avenues for partnerships with payers and claims managers.

Strong Industry Collaborations Partnerships with Veterans Affairs and collaborations testing hospice care suggest applications for diverse patient populations, which can be leveraged to approach government agencies, healthcare networks, and long-term care providers for broader deployment.

Funding & Growth Potential With over 97 million dollars raised and a growing revenue base, AppliedVR is positioned as a financially robust company with significant potential for scaling its immersive therapeutics platform across various clinical settings and markets.

Market Leadership & First Mover Advantage As the first FDA-authorized VR device with a designated CMS coverage category, AppliedVR holds a competitive edge that can be utilized to engage healthcare organizations, payers, and policymakers interested in innovative, reimbursable pain management solutions.